Lexaria Change In Cash from 2010 to 2024

LEXXW Stock  USD 0.80  0.05  6.67%   
Lexaria Bioscience Change In Cash yearly trend continues to be fairly stable with very little volatility. Change In Cash is likely to outpace its year average in 2024. During the period from 2010 to 2024, Lexaria Bioscience Change In Cash regression line of quarterly data had mean square error of 14.2 T and geometric mean of  775,603. View All Fundamentals
 
Change In Cash  
First Reported
2005-11-30
Previous Quarter
3.8 M
Current Value
-2 M
Quarterly Volatility
1.5 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Lexaria Bioscience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Lexaria Bioscience's main balance sheet or income statement drivers, such as Depreciation And Amortization of 132.7 K, Interest Expense of 125.2 K or Other Operating Expenses of 3.2 M, as well as many indicators such as Price To Sales Ratio of 105, Dividend Yield of 0.0 or PTB Ratio of 54.87. Lexaria financial statements analysis is a perfect complement when working with Lexaria Bioscience Valuation or Volatility modules.
  
Check out the analysis of Lexaria Bioscience Correlation against competitors.

Latest Lexaria Bioscience's Change In Cash Growth Pattern

Below is the plot of the Change In Cash of Lexaria Bioscience Corp over the last few years. It is Lexaria Bioscience's Change In Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Lexaria Bioscience's overall financial position and show how it may be relating to other accounts over time.
Change In Cash10 Years Trend
Pretty Stable
   Change In Cash   
       Timeline  

Lexaria Change In Cash Regression Statistics

Arithmetic Mean777,132
Geometric Mean775,603
Coefficient Of Variation478.06
Mean Deviation2,612,644
Median(114,972)
Standard Deviation3,715,193
Sample Variance13.8T
Range14.7M
R-Value0.21
Mean Square Error14.2T
R-Squared0.04
Significance0.45
Slope175,266
Total Sum of Squares193.2T

Lexaria Change In Cash History

20245.4 M
20235.1 M
2022-4.5 M
2021-5.1 M
20209.6 M
2019 8602.0
2018-442 K

About Lexaria Bioscience Financial Statements

Lexaria Bioscience investors use historical fundamental indicators, such as Lexaria Bioscience's Change In Cash, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Lexaria Bioscience. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Change In Cash5.1 M5.4 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Lexaria Stock Analysis

When running Lexaria Bioscience's price analysis, check to measure Lexaria Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lexaria Bioscience is operating at the current time. Most of Lexaria Bioscience's value examination focuses on studying past and present price action to predict the probability of Lexaria Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lexaria Bioscience's price. Additionally, you may evaluate how the addition of Lexaria Bioscience to your portfolios can decrease your overall portfolio volatility.